SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors anticipate critical clinical trial results and a potential acquisition, fueling a technical short squeeze driven by record short interest. The community is actively discussing the stock's parabolic move and the strategic implications of recent corporate filings ahead of imminent trial data readouts.

LightPath Technologies, Inc. engages in the design, development, manufacture, and distribution of optical and infrared components. Its products include molded glass and assemblies, infrared molded lenses, diamond turned, conventional ground and polished ground lenses and assemblies, and collimator assemblies, which are used in applications involving light detection and ranging technology. The firm supports a range of customers in the field of industrial, laser, defense, medical, telecommunications, and instrumentation. The company was founded in1985 and is headquartered in Orlando, FL.

Lightpath Technologies, Inc. - Ordinary Shares - Class A

Lightpath Technologies is trending due to strong financial performance and continued momentum in its defense-focused infrared optics and assembly business, which is benefiting from a push toward domestic sourcing. The community is actively discussing the company's strategic position in the U.S. defense supply chain, the ongoing replacement of Germanium with proprietary BlackDiamond materials, and potential involvement in high-profile military programs like the NGSRI.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending as investors aggressively rotate into physical AI and robotics infrastructure, bolstered by a new analyst coverage initiating with a $75 price target. The community is actively discussing Ouster's integration into Amazons robotics supply chain, its competitive advantage in native color LiDAR technology, and the potential for a sustained multi-year breakout as it secures dominance in the U.S. defense and smart infrastructure sectors.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is currently experiencing significant market attention as traders balance the impact of heightened geopolitical volatility in the Middle East with the company's strong dividend profile and ongoing operational expansion. The community is actively debating the stock's resilience against volatile oil futures, with many investors focusing on whether current support levels near the 200-day moving average provide a buying opportunity amid persistent regulatory scrutiny and supply-demand imbalances.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund is experiencing heightened volatility as investors weigh the impact of persistent supply disruptions in the Strait of Hormuz against ongoing, yet inconclusive, diplomatic negotiations between the U.S. and Iran. The community remains deeply divided, with many traders closely monitoring inventory depletion rates and shipping traffic as key indicators of whether the sector is facing a structural energy supply crisis or a temporary geopolitical premium.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc is currently attracting significant community attention following its latest quarterly earnings report, which highlighted record profitability and the launch of a $75 million share buyback program. While bulls are energized by these financial improvements and new strategic partnerships, the broader conversation remains divided as skeptics point to stalled policy growth and a history of volatility, leaving investors closely watching whether these new initiatives can sustain long-term momentum.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix Inc. is trending as investors digest a strong earnings report and raised full-year guidance, with community discussion focused on the potential for institutional accumulation and the ongoing commercial buildout for the company's broader anti-infective platform. While some shareholders are debating the long-term growth outlook and patient adoption metrics, many are actively monitoring the stock's ability to maintain upward momentum as they look for catalysts beyond the DefenCath franchise.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending as investors weigh recent debt repurchases against ongoing uncertainty surrounding the EMA regulatory timeline and the competitive landscape for its lead therapy. The community is actively debating the company's long-term commercial potential, the impact of recent leadership departures, and the significance of upcoming catalysts like J-code implementation.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific (CORZ) is trending as investors focus on its pivot from Bitcoin mining to high-performance AI data center infrastructure, fueled by massive multi-year hosting contracts with CoreWeave. Community discussions are heavily focused on the company's expanding gigawatt power pipeline and institutional accumulation, with traders closely watching for upcoming earnings and the potential announcement of new anchor tenants to drive the next leg of growth.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors debate the impact of the newly launched DKeX proprietary prediction exchange, with some seeing it as a transformative tool for nationwide expansion and market independence, while others remain skeptical due to increased competition from Meta and ongoing regulatory scrutiny. Community sentiment is deeply divided, characterized by intense friction between long-term bulls highlighting strong prediction volume and growth potential and bearish traders pointing to management's share selling and stagnant price action compared to broader market trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why City Holding (CHCO) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does City Holding (CHCO) have what it takes? Let's find out.

City Holding (CHCO) Upgraded to Buy: Here's Why

City Holding (CHCO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Why City Holding (CHCO) is a Top Dividend Stock for Your Portfolio

City Holding (CHCO) is a Top Dividend Stock Right Now: Should You Buy?

Is the Options Market Predicting a Spike in City Holding Stock?

Investors need to pay close attention to CHCO stock based on the movements in the options market lately.

City Holding (CHCO) Could Be a Great Choice

City (NASDAQ:CHCO) CEO Charles Hageboeck Sells 5,855 Shares of Stock

City Holding Company (NASDAQ:CHCO - Get Free Report) CEO Charles Hageboeck sold 5,855 shares of the firm's stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price...

City (NASDAQ:CHCO) CEO Sells $733,631.50 in Stock

City Holding Company (NASDAQ:CHCO - Get Free Report) CEO Charles Hageboeck sold 5,855 shares of the stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of...

CHCO Trading Below Director's Recent Buy Price

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on April 20, City Holding Co.'s Director, Diane W...

City Holding Company Shareholders Elect B. Scott Raynes to Board of Directors

The shareholders of City Holding Company, the Company (NASDAQ: CHCO), have elected B. Scott Raynes to its Board of Directors as a Class II director to serve for a term of two-years at its Annual...

City Holding Co. is a financial holding company, which engages in the provision of financial and community banking services. Its products produced and services rendered by City National include Commercial Banking, Consumer Banking, Mortgage Banking, and Wealth Management and Trust Services. The company was founded on March 12, 1982 and is headquartered in Charleston, WV.

City Holding Co.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$2.22	--	--	N/A
Q1 '26	$2.15	$2.20	2.52%	BEAT
Q4 '25	$2.26	$2.18	-3.63%	MISSED
Q3 '25	$2.15	$2.41	11.83%	BEAT
Q2 '25	$1.96	$2.29	16.96%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

CHCOCity Holding Co.

Upcoming Earnings: Q2 '26

Historical Earnings

Latest CHCO News